TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15082970

Group type: EXPERIMENTAL
Intervention: Bioartificial liver (BAL)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control
Number of subjects: 171
Study: 11195891

Group type: EXPERIMENTAL
Intervention: Believing that one's bad mood was frozen (unchangeable)
Number of subjects: 0
Study: 9627664

Group type: EXPERIMENTAL
Intervention: EXT‐DCR
Number of subjects: 64

Group type: COMPARATOR
Intervention: ENL‐DCR
Number of subjects: 64
Study: 7931615

Group type: EXPERIMENTAL
Intervention: Craniospinal local-boost radiotherapy and adjuvant chemotherapy with vincristine weekly during radiotherapy followed by eight 6-week cycles of cisplatin, CCNU, and vincristine.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Reduced-dose craniospinal radiotherapy (2400 cGy).
Number of subjects: 63
Study: 2979239

Group type: EXPERIMENTAL
Intervention: Trimoprostil (3 mg b.d.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30100283

Group type: EXPERIMENTAL
Intervention: Kinesio Taping® elastic tape applied for muscle facilitation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Kinesio Taping® elastic tape applied for muscle inhibition
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no Kinesio Taping® elastic tape)
Number of subjects: 36
Study: 28764753

Group type: EXPERIMENTAL
Intervention: Complex intervention involving training videos and a template for conducting an individualised structured medication review.
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 450
Study: 25362584

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (16 sessions of NFB)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 24
Study: 24440473

Group type: COMPARATOR
Intervention: Preoperative radiotherapy (45 Gy in 25 fractions of 1.8 Gy over 5 weeks)
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy with concomitant chemotherapy (fluorouracil 350 mg/m² per day intravenous bolus and folinic acid 20 mg/m² per day intravenous bolus)
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (four cycles every 3 weeks)
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Surveillance after preoperative radiotherapy
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Preoperative radiotherapy
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy with chemotherapy
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Preoperative radiotherapy alone
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiotherapy and chemotherapy
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Radiotherapy and adjuvant chemotherapy
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Both adjuvant and neoadjuvant chemotherapy
Number of subjects: 1011
Study: 22441231

Group type: EXPERIMENTAL
Intervention: Multimedia online resources (n=8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional written material (Control group, n=8)
Number of subjects: 16
Study: 19597863

Group type: EXPERIMENTAL
Intervention: Subcutaneous TBA (Group A)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Subfascial TBA (Group B)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Submuscular TBA (Group C)
Number of subjects: 53
Study: 17498584

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 9478

Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 9478
Study: 15362015

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy (weekly individual sessions for four months)
Number of subjects: 48
Study: 11346715

Group type: EXPERIMENTAL
Intervention: Mepartricin 40 mg/die for 60 days
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (C vitamin 500 mg/die) for 60 days
Number of subjects: 42
Study: 9716008

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Busulfan
Number of subjects: 159
Study: 8732233

Group type: EXPERIMENTAL
Intervention: Unilateral nasal allergen challenge
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diluent
Number of subjects: 6
Study: 2252123

Group type: EXPERIMENTAL
Intervention: Three-drug sequential immunosuppression (Minnesota antilymphocyte globulin, prednisone, azathioprine, and cyclosporine) (n = 107)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Two-drug sequential immunosuppression (Minnesota antilymphocyte globulin, prednisone, and cyclosporine) (n = 45)
Number of subjects: 152
Study: 7027747

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium-albumin (GIKA) infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5.5% glucose infusion (Control)
Number of subjects: 50
Study: 29347863

Group type: EXPERIMENTAL
Intervention: Psychoeducation plus exercise (PE + EX)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Psychoeducation only (PE)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Usual care attention control (UCAC)
Number of subjects: 127
Study: 31072867

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemotherapy alone
Number of subjects: 0
Study: 28329190

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV+AIDSVAX B/E
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E
Number of subjects: 162

Group type: COMPARATOR
Intervention: ALVAC-HIV
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 25984959

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Culturally Adapted Motivational Interviewing (CAMI)
Number of subjects: 20
Study: 25566977

Group type: EXPERIMENTAL
Intervention: 2 g of piperacillin (PIPC) administered intravenously immediately after endotracheal intubation (Group A)
Number of subjects: 2164

Group type: EXPERIMENTAL
Intervention: 1 g of cefazolin (CEZ) administered intravenously immediately after endotracheal intubation (Group B)
Number of subjects: 2164

Group type: COMPARATOR
Intervention: Control group (Group C) did not receive AMP
Number of subjects: 2164
Study: 21765120

Group type: EXPERIMENTAL
Intervention: Comprehensive self-management (CSM) intervention
Number of subjects: 188

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 188
Study: 19714296

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus Enzastaurin (GE); E 500 mg p.o. daily; loading-dose (1200 mg; Day 1 Cycle 1 only) and G 1000 mg/m2 i.v. Days 1, 8, and 15 in 28-day cycles
Number of subjects: 130

Group type: COMPARATOR
Intervention: Single-agent Gemcitabine (G); G as in GE
Number of subjects: 130
Study: 18059013

Group type: EXPERIMENTAL
Intervention: Trachea spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Molecular water (vaporizing humidifier)
Number of subjects: 0
Study: 16824841

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 75 mg rPSGL-Ig
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 150 mg rPSGL-Ig
Number of subjects: 88
Study: 12845504

Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg) in monotherapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg) with folate (10 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fluvastatin (40 mg followed by 80 mg)
Number of subjects: 24
Study: 10685789

Group type: COMPARATOR
Intervention: cA2 monoclonal antibody (1 mg/kg or 10 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: cA2 monoclonal antibody (3 mg/kg or 10 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9671161

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 100 microg three times a day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Disodium cromoglycate (DSCG) 10 mg three times a day
Number of subjects: 15
Study: 10172083

Group type: EXPERIMENTAL
Intervention: rhGM-CSF
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2736884

Group type: EXPERIMENTAL
Intervention: Angiotensin II (ANG II; 1 ng min‐1 kg‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 5% (w/v) D‐glucose (placebo)
Number of subjects: 6
Study: 5005719

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (Intal)
Number of subjects: 22
Study: 31335316

Group type: EXPERIMENTAL
Intervention: Extended 16 week course of prednisolone (total dose 3150 mg/m2)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Standard 8 week course of prednisolone (total dose 2240 mg/m2)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Extended 16 week course of prednisolone
Number of subjects: 237

Group type: COMPARATOR
Intervention: Standard 8 week course of prednisolone
Number of subjects: 237
Study: 28844786

Group type: EXPERIMENTAL
Intervention: Online survey questionnaire with paper reminder (N = 2,982)
Number of subjects: 5837

Group type: COMPARATOR
Intervention: Paper questionnaire with electronic reminder (N = 2,855)
Number of subjects: 5837
Study: 25892528

Group type: EXPERIMENTAL
Intervention: MPE + WG group
Number of subjects: 40

Group type: COMPARATOR
Intervention: WG group
Number of subjects: 40
Study: 23507359

Group type: EXPERIMENTAL
Intervention: MATRICS Consensus Cognitive Battery (MCCB)
Number of subjects: 183
Study: 22037068

Group type: EXPERIMENTAL
Intervention: Subconjunctival anesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 90
Study: 18258419

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 60
Study: 16492212

Group type: EXPERIMENTAL
Intervention: Insulin glargine + insulin lispro
Number of subjects: 56

Group type: COMPARATOR
Intervention: NPH insulin + unmodified human insulin
Number of subjects: 56
Study: 14586797

Group type: EXPERIMENTAL
Intervention: Clodronate (300 mg intravenous infusion every 3 weeks for 2 years)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Calcium and vitamin D (active placebo)
Number of subjects: 30
Study: 10866444

Group type: EXPERIMENTAL
Intervention: CD34-selected grafts
Number of subjects: 40

Group type: COMPARATOR
Intervention: CD34-unselected grafts
Number of subjects: 40
Study: 9268811

Group type: EXPERIMENTAL
Intervention: Directed attention (gaze) at the responding hand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Looking away from the responding hand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crossed arm posture with directed attention at the expected side
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncrossed arm posture
Number of subjects: 0
Study: 7926135

Group type: EXPERIMENTAL
Intervention: Unilateral laparoscopic ovarian diathermy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bilateral laparoscopic ovarian diathermy
Number of subjects: 10
Study: 3192670

Group type: EXPERIMENTAL
Intervention: Focused casework approach to the whole family
Number of subjects: 0

Group type: COMPARATOR
Intervention: Structured play therapy approach to the child
Number of subjects: 0
Study: 31192355

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy) and three cycles of FOLFOX4
Number of subjects: 515

Group type: COMPARATOR
Intervention: Chemoradiation (50.4 Gy with bolus 5-Fu, leucovorin and oxaliplatin)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Short-course/CCT
Number of subjects: 515

Group type: COMPARATOR
Intervention: Chemoradiation
Number of subjects: 515
Study: 28316148

Group type: EXPERIMENTAL
Intervention: Direct current cardioversion (Group 1; n = 45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Linear lesions (Group 2; n = 45)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Direct current cardioversion (Group 1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Linear lesions (Group 2)
Number of subjects: 90
Study: 25444682

Group type: EXPERIMENTAL
Intervention: Red Bull
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Red Bull Light
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Suso Orange
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control drink (Suso Orange)
Number of subjects: 16
Study: 23302264

Group type: EXPERIMENTAL
Intervention: Catgut implantation at acupoints
Number of subjects: 242

Group type: COMPARATOR
Intervention: Sham catgut implantation at acupoints
Number of subjects: 242
Study: 21345773

Group type: EXPERIMENTAL
Intervention: Subzero-balanced ultrafiltration (SBUF)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no SBUF)
Number of subjects: 94
Study: 18583332

Group type: EXPERIMENTAL
Intervention: Highly purified hMG (hp-hMG)
Number of subjects: 280

Group type: COMPARATOR
Intervention: recombinant FSH (rFSH)
Number of subjects: 280
Study: 16780391

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pravastatin 10-40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colestyramine 12 g/day
Number of subjects: 0
Study: 12932068

Group type: EXPERIMENTAL
Intervention: Sevoflurane (Group S)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA) (Group TIVA)
Number of subjects: 42
Study: 10865304

Group type: EXPERIMENTAL
Intervention: Exercise training (2 weeks of in-hospital ergometer exercise for 10 minutes 4 to 6 times per day, followed by 6 months of home-based ergometer exercise training for 20 minutes per day at 70% of peak oxygen uptake)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 73
Study: 9106920

Group type: EXPERIMENTAL
Intervention: Pelvic radiotherapy (RT)
Number of subjects: 1619
Study: 1550076

Group type: EXPERIMENTAL
Intervention: Cyclic PAC chemotherapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Brief PAC chemotherapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: FAM chemotherapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Cyclic PAC chemotherapy (Stage III or IV)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Brief PAC chemotherapy (Stage III or IV)
Number of subjects: 99

Group type: COMPARATOR
Intervention: FAM chemotherapy (Stage III or IV)
Number of subjects: 99
Study: 3901359

Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 30813857

Group type: EXPERIMENTAL
Intervention: Male students
Number of subjects: 2827

Group type: EXPERIMENTAL
Intervention: Students whose mothers smoked
Number of subjects: 2827

Group type: EXPERIMENTAL
Intervention: Students whose mothers had a higher educational level
Number of subjects: 2827

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 2827

Group type: EXPERIMENTAL
Intervention: Former smokers
Number of subjects: 2827

Group type: EXPERIMENTAL
Intervention: Students for whom most of their closest friends were smokers
Number of subjects: 2827

Group type: EXPERIMENTAL
Intervention: Students for whom a few of their closest friends were smokers
Number of subjects: 2827
Study: 29172608

Group type: EXPERIMENTAL
Intervention: Multivariate approach using standardized outcomes
Number of subjects: 0
Study: 27714758

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca block with 2 mg.kg-1 levobupivacaine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Spinal morphine 100 μg plus a sham ultrasound-guided fascia iliaca block using saline
Number of subjects: 108
Study: 23716037

Group type: EXPERIMENTAL
Intervention: Odanacatib 10 mg
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Odanacatib 25 mg
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Odanacatib 50 mg
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study: 23019990

Group type: EXPERIMENTAL
Intervention: Neutral barium sulphate suspension (900 ml, 0.1% w/v)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Positive barium sulphate suspension (900 ml, 2.1% w/v)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Water (900 ml)
Number of subjects: 156
Study: 20238255

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at a dose of 0.29 IU.min(‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Initial dose of oxytocin infusion was 0.4 IU.min(‐1)
Number of subjects: 40
Study: 17512704

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg once daily
Number of subjects: 689

Group type: COMPARATOR
Intervention: Cefuroxime 250 mg twice daily
Number of subjects: 689
Study: 16015542

Group type: EXPERIMENTAL
Intervention: Amifostine (AMF)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control
Number of subjects: 62
Study: 12368510

Group type: EXPERIMENTAL
Intervention: Closed-cell stent (NIR)
Number of subjects: 54
Study: 10404959

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7752586

Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐1 (rhIGF‐1) 50 micrograms/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐1 (rhIGF‐1) 100 micrograms/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐1 (rhIGF‐1)
Number of subjects: 18
Study: 2281247

Group type: EXPERIMENTAL
Intervention: GHB (25 mg/kg h.s. and 3 h later)
Number of subjects: 20
Study: 7330791

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of aminophylline and salbutamol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31136202

Group type: EXPERIMENTAL
Intervention: Heat therapy (HT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 18
Study: 28937248

Group type: EXPERIMENTAL
Intervention: Intermittent TBS (iTBS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham (intermediate TBS; imTBS)
Number of subjects: 19
Study: 25001020

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine device (LNG-IUD)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Dydrogesterone (oral)
Number of subjects: 138
Study: 23328689

Group type: EXPERIMENTAL
Intervention: Angioplasty and stenting for ICAD
Number of subjects: 21
Study: 21122856

Group type: EXPERIMENTAL
Intervention: Plant sterol enriched margarine (2.5g/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plant stanol enriched margarine (2.5g/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-enriched margarine (2.5g/day)
Number of subjects: 30
Study: 20423760

Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (7 mmHg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard pressure pneumoperitoneum (12-15 mmHg)
Number of subjects: 68
Study: 16458215

Group type: EXPERIMENTAL
Intervention: Sevoflurane 2% in cardioplegic mixture
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no sevoflurane in cardioplegia)
Number of subjects: 21
Study: 14969664

Group type: EXPERIMENTAL
Intervention: 20 microg ethinylestradiol (EE) + 100 microg levonorgestrel (LNG) (20/100)
Number of subjects: 48

Group type: COMPARATOR
Intervention: 30 microg ethinylestradiol (EE) + 150 microg levonorgestrel (LNG) (30/150)
Number of subjects: 48
Study: 11270908

Group type: EXPERIMENTAL
Intervention: Alprazolam-XR (4 mg/day mean dose)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 9815742

Group type: EXPERIMENTAL
Intervention: Acyclic retinoid (600 mg daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Acyclic retinoid
Number of subjects: 42
Study: 8179133

Group type: EXPERIMENTAL
Intervention: Cemented components
Number of subjects: 20

Group type: COMPARATOR
Intervention: Uncemented components
Number of subjects: 20
Study: 3345456

Group type: EXPERIMENTAL
Intervention: Tizanidine (Sirdalud)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Baclofen (Lioresal)
Number of subjects: 66
Study: 31201109

Group type: EXPERIMENTAL
Intervention: Foam bleomycin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Liquid bleomycin
Number of subjects: 30
Study: 29764409

Group type: EXPERIMENTAL
Intervention: Quadriceps-plus-hip-abductor-strengthening
Number of subjects: 80

Group type: COMPARATOR
Intervention: Quadriceps-strengthening
Number of subjects: 80
Study: 26657031

Group type: EXPERIMENTAL
Intervention: Tong Len meditation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups (Tong Len and Control)
Number of subjects: 103
Study: 24797698

Group type: EXPERIMENTAL
Intervention: Glidescope®
Number of subjects: 23

Group type: COMPARATOR
Intervention: Miller laryngoscope
Number of subjects: 23

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 23

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 23
Study: 23419999

Group type: EXPERIMENTAL
Intervention: Intervention DFACs
Number of subjects: 602
Study: 19897064

Group type: EXPERIMENTAL
Intervention: Leisure physical activity participation (TAS mean=105, range=0‐840)
Number of subjects: 234
Study: 18062830

Group type: EXPERIMENTAL
Intervention: High folate intake (highest tertile)
Number of subjects: 1864

Group type: COMPARATOR
Intervention: Low folate intake (lowest tertile)
Number of subjects: 1864

Group type: COMPARATOR
Intervention: Folate intake (general)
Number of subjects: 1864
Study: 16424795

Group type: EXPERIMENTAL
Intervention: Lercanidipine 20 mg/d for 15 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo for 15 days
Number of subjects: 14
Study: 14976862

Group type: EXPERIMENTAL
Intervention: Guideline-based intervention (early echocardiography, aggressive diuretic therapy, comprehensive education, prescribed diet, intensive pharmacological therapy)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (normal discharge after longer stay)
Number of subjects: 100
Study: 10702763

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg per os, once a day
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109